About Launch Therapeutics
Launch Therapeutics is a company based in Boston (United States) founded in 2022. Launch Therapeutics offers products and services including Drug Development Solutions. Launch Therapeutics operates in a competitive market with competitors including United BioSource Corporation, Xgene Pharmaceutical, Hikinger Pharmaceutical Technology, Ipsum and Concentrics Research, among others.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Launch Therapeutics
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Launch Therapeutics
Launch Therapeutics offers a comprehensive portfolio of products and services, including Drug Development Solutions.
Services to accelerate regulatory and clinical processes for biopharma.
People of Launch Therapeutics
Unlock access to complete
Funding Insights of Launch Therapeutics
Detailed funding history for Launch Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Launch Therapeutics
Investment portfolio details for Launch Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Launch Therapeutics
Detailed financials for Launch Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Launch Therapeutics Comparisons
Peer comparison for Launch Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Launch Therapeutics
Launch Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as United BioSource Corporation, Xgene Pharmaceutical, Hikinger Pharmaceutical Technology, Ipsum and Concentrics Research, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical support services
|
|
| Locked | Locked | Locked |
Developer of pharmaceutical products for treating neurological diseases and chronic pain
|
|
| Locked | Locked | Locked |
Phase I-IV drug research and development services are provided.
|
|
| Locked | Locked | Locked |
Full-service CRO support for Phase II-IV clinical trials is provided.
|
|
| Locked | Locked | Locked |
Late-stage (Phase II-IV trials) CRO
|
Detailed competitors of Launch Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Launch Therapeutics
Complete news archive for Launch Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Launch Therapeutics
Launch Therapeutics was founded in 2022.
Launch Therapeutics is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Anshul Thakral is the current CEO of Launch Therapeutics.
Launch Therapeutics was founded in 2022 in Boston, United States, as a provider of late-stage clinical development services targeted at the biopharma sector. Operations focus on supporting biopharmaceutical firms through clinical trial management, regulatory guidance, and development optimization. Services are delivered to clients seeking to advance therapies toward market approval, with leadership under CEO Anshul Thakral. The company operates primarily in the United States healthcare ecosystem.
Launch Therapeutics's top competitors include United BioSource Corporation, Xgene Pharmaceutical and Concentrics Research.
Launch Therapeutics offers Drug Development Solutions.